Phase I trial of lestaurtinib for children with refractory neuroblastoma: a new approaches to neuroblastoma therapy consortium study

PURPOSE: TrkB acts as an oncogenic kinase in a subset of human neuroblastomas. Lestaurtinib, a multi-kinase inhibitor with potent activity against Trk kinases, has demonstrated activity in preclinical models of neuroblastoma. METHODS: Patients with refractory high-risk neuroblastoma received lestaur...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cancer Chemother Pharmacol
Egile Nagusiak: Minturn, Jane E., Evans, Audrey E., Villablanca, Judith G., Yanik, Gregory A., Park, Julie R., Shusterman, Suzanne, Groshen, Susan, Hellriegel, Edward T., Bensen-Kennedy, Debra, Matthay, Katherine K., Brodeur, Garrett M., Maris, John M.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2011
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4238911/
https://ncbi.nlm.nih.gov/pubmed/21340605
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-011-1581-4
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak